By collaborating with diverse public- and private-sector partners, PATH provides appropriate health technologies designed for low resource environments such as more effective diagnostic technologies, solutions to malnutrition such as UltraRice®, simple innovations which continue to save birthing mothers and newborn babies, specialized syringes and needles, improved vaccines and vaccine delivery methods, and many more.
Established nearly 40 years ago, PATH now works in nearly 70 countries around the globe, and has more than 1,300 employees worldwide. Its multidisciplinary staff range from scientists and experts in public health to policy and business strategists. PATH is world-renowned for its innovative approach to improving health technologies. It has been at the forefront of creating technologies that have fundamentally impacted countries around the globe.
PATH's executive team consists of its president and CEO, Steve Davis; four vice presidents; a chief strategy officer, human resources officer, financial officer, and operating officer; and general counsel. The executive team is responsible for PATH's strategy, finances, and management - as well as PATH's overall success in achieving its mission. The 11 members of PATH's board of directors are public health and business leaders from the United States and the countries it serves. The board provides governance and fiduciary oversight, sets policy, and assesses PATH's overall performance.
In addition, PATH relies on an internationally recognized group of program leaders, including experts on specific diseases, immunization, maternal and child health, reproductive health, technology development, and vaccine development.
PATH has had consistent financial stability and continues to grow. Since the organization was established in 1977, its revenue has increased from less than $20 million to more than $300 million. This growth has occurred across all of PATH's areas of focus, from emerging and epidemic diseases (for example, HIV, tuberculosis, and malaria) to new vaccines to innovative technologies for low-resource settings.
In 2012 PATH's total revenue was $312,819,000. This funding comes from foundations, the US government and other governments, other nonprofit organizations, multilateral agencies such as the World Health Organization, individuals, and interest from investments. More than 85 percent of its expenses go toward programs to improve the health of people around the world.
For ten years in a row, PATH has maintained Charity Navigator's highest possible ranking - four stars. Private support from individuals, foundations, and corporations is critical to the organization's success.
(Evaluated by the Seattle International Foundation, a supporting organization of The Seattle Foundation)